Author: Selina McKee

The number of children being vaccinated in England falls again

A new report from NHS Digital shows that a decreasing number of children are being vaccinated against potentially deadly or life-altering diseases such as tetanus, diphtheria and polio

Almirall steps into psoriasis market with Ilumetri approval

The European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis.

Actelion’s Opsumit shows promise in portopulmonary hypertension

Actelion has unveiled new data showing that the first ever randomised, controlled clinical trial investigating Opsumit as potential treatment for portopulmonary hypertension (PoPH) hit its primary target.

Allergan, Sosei suspend clinical development of dementia drug

Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.

AZ’ Fasenra shows long-term efficacy in eosinophilic asthma

AstraZeneca has unveiled data from a Phase III extension trial highlighting the efficacy of biologic Fasenra as an add-on maintenance treatment in patients with severe eosinophilic asthma.